Testing effectiveness (Phase 2)Study completedNCT00003131What this trial is testingCMA-676 in Treating Patients With Acute Myeloid Leukemia in First RelapseWho this might be right forLeukemia Pfizer 55
Not applicableUnknownNCT03173612What this trial is testingThe Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Institute of Hematology & Blood Diseases Hospital, China 132
Large-scale testing (Phase 3)Ended earlyNCT03547154What this trial is testingPolyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)Who this might be right forChronic Myelogenous Leukemia Merck Sharp & Dohme LLC 344
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Early research (Phase 1)WithdrawnNCT05456269What this trial is testingBisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDSWho this might be right forAcute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+2 more Racura Oncology Ltd
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Large-scale testing (Phase 3)UnknownNCT01615757What this trial is testingSafety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML ConsolidationWho this might be right forAcute Myeloid Leukemia All India Institute of Medical Sciences 180
Not applicableActive Not RecruitingNCT04167683What this trial is testingMuscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantWho this might be right forHematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more Rigshospitalet, Denmark 144
Early research (Phase 1)Study completedNCT00038051What this trial is testingEvaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid MalignanciesWho this might be right forAcute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyeloproliferative Disorders+1 more M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00005802What this trial is testingChemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02017457What this trial is testingAzacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.Who this might be right forAcute Myelogenous LeukemiaMyelodysplastic Syndrome Carlos Graux, MD, PhD 50
Early research (Phase 1)Ended earlyNCT01159301What this trial is testingEntinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Ended earlyNCT03214666What this trial is testingGTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological MalignanciesWho this might be right forHigh-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more GT Biopharma, Inc. 12
Early research (Phase 1)Looking for participantsNCT05101551What this trial is testingStudy of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and EfficacyWho this might be right forAcute Myeloid Leukemia Norman J. Lacayo 34
Not applicableNot Yet RecruitingNCT07572695What this trial is testingSalvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AMLWho this might be right forAcute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid LeukemiaAML, Relapsed/Refractory Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Early research (Phase 1)Study completedNCT04372433What this trial is testingIO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMMLWho this might be right forAML With Monocytic DifferentiationCMML Immune-Onc Therapeutics 67
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT04938115What this trial is testingCell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage LeukemiaWho this might be right forLeukemia, T Cell Hebei Senlang Biotechnology Inc., Ltd. 50
Early research (Phase 1)WithdrawnNCT01478074What this trial is testingALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Altor BioScience
Post-approval studies (Phase 4)Study completedNCT02546674What this trial is testingStudy Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.Who this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 171